{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:47:01Z","timestamp":1781678821882,"version":"3.54.5"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.canrad.2018.01.003","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T09:18:13Z","timestamp":1524475093000},"page":"287-295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Adaptive radiotherapy for head and neck cancers: Fact or fallacy to improve therapeutic ratio?"],"prefix":"10.1016","volume":"22","author":[{"given":"Y.Q.","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.S.H.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.T.S.","family":"Wee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.K.","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2018.01.003_bib0295","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study","volume":"3","author":"Fitzmaurice","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.canrad.2018.01.003_bib0300","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2018.01.003_bib0305","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0140-6736(15)00055-0","article-title":"Nasopharyngeal carcinoma","volume":"387","author":"Chua","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2018.01.003_bib0310","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.21037\/cco.2017.06.31","article-title":"Exploiting molecular genomics in precision radiation oncology: a marriage of biological and physical precision","volume":"6","author":"Tan","year":"2017","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.canrad.2018.01.003_bib0315","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/jnci\/djn460","article-title":"Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy","volume":"101","author":"Lefebvre","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canrad.2018.01.003_bib0320","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJM199106133242402","article-title":"Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal, cancer","volume":"324","author":"Department of Veterans Affairs Laryngeal Cancer Study Group","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2018.01.003_bib0325","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.radonc.2014.02.003","article-title":"Evolution of treatment for nasopharyngeal cancer \u2013 success and setback in the intensity-modulated radiotherapy era","volume":"110","author":"Lee","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2018.01.003_bib0330","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13014-014-0318-z","article-title":"Impact of head and neck cancer adaptive radiotherapy to spare the parotid glands and decrease the risk of xerostomia","volume":"10","author":"Castelli","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2018.01.003_bib0335","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.radonc.2012.10.010","article-title":"Adaptive radiotherapy for head and neck cancer \u2013 dosimetric results from a prospective clinical trial","volume":"106","author":"Schwartz","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2018.01.003_bib0340","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.radonc.2011.06.011","article-title":"Adaptive functional image-guided IMRT in pharyngo-laryngeal squamous cell carcinoma: is the gain in dose distribution worth the effort?","volume":"101","author":"Castadot","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2018.01.003_bib0345","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.ijrobp.2003.12.024","article-title":"Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT\/linear accelerator system","volume":"59","author":"Barker","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2018.01.003_bib0350","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1200\/JCO.2015.61.2994","article-title":"Advances in radiotherapy for head and neck cancer","volume":"33","author":"Gregoire","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2018.01.003_bib0355","doi-asserted-by":"crossref","first-page":"371","DOI":"10.21037\/tcr.2016.07.18","article-title":"Radiomics in head and neck cancer: from exploration to application","volume":"5","author":"Wong","year":"2016","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.canrad.2018.01.003_bib0360","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1038\/ncomms5006","article-title":"Decoding tumour phenotype by non-invasive imaging using a quantitative radiomics approach","volume":"5","author":"Aerts","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.canrad.2018.01.003_bib0365","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.ijrobp.2012.09.033","article-title":"Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma","volume":"85","author":"Yang","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2018.01.003_bib0370","doi-asserted-by":"crossref","first-page":"6076","DOI":"10.1200\/JCO.2017.35.15_suppl.6076","article-title":"A personalized approach using hypoxia resolution to guide curative-intent radiation dose-reduction to 30Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers (OPC)","volume":"35","author":"Riaz","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2018.01.003_bib0375","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1200\/JCO.2002.20.5.1398","article-title":"Standardized uptake value of 2-(18F)-fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy","volume":"20","author":"Allal","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2018.01.003_bib0380","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.ijrobp.2003.12.039","article-title":"Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-(18F)-fluoro-2-deoxy-D-glucose","volume":"59","author":"Allal","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2018.01.003_bib0385","first-page":"253","article-title":"Prognostic impact of hypoxia imaging with (18F)-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy","volume":"46","author":"Eschmann","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.canrad.2018.01.003_bib0390","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1200\/JCO.2005.05.2878","volume":"24","author":"Rischin","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2018.01.003_bib0395","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2012.08.019","article-title":"Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer","volume":"105","author":"Zips","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2018.01.003_bib0400","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s00259-014-2810-y","article-title":"Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma","volume":"41","author":"Sato","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.canrad.2018.01.003_bib0405","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.radonc.2012.09.015","article-title":"FAZA PET\/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial","volume":"105","author":"Mortensen","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2018.01.003_bib0410","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1007\/s00259-014-2818-3","article-title":"Prognostic value of tumour blood flow, (18F)-EF5 and (18F)-FDG PET\/CT imaging in patients with head and neck cancer treated with radiochemotherapy","volume":"41","author":"Komar","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.canrad.2018.01.003_bib0415","doi-asserted-by":"crossref","first-page":"532","DOI":"10.2967\/jnumed.112.105999","article-title":"(18F)-FLT PET during radiotherapy or chemoradiotherapy in head and neck squamous cell carcinoma is an early predictor of outcome","volume":"54","author":"Hoeben","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.canrad.2018.01.003_bib0420","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00259-016-3345-1","article-title":"RGD-K5 PET\/CT in patients with advanced head and neck cancer treated with concurrent chemoradiotherapy: results from a pilot study","volume":"43","author":"Chen","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.canrad.2018.01.003_bib0425","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4103\/1450-1147.207273","article-title":"(18F)-fluorodeoxyglucose-positron emission tomography\/computed tomography imaging of metastatic nasopharyngeal cancer with emphasis on the distribution of bone metastases","volume":"16","author":"Al Tamimi","year":"2017","journal-title":"World J Nucl Med"},{"key":"10.1016\/j.canrad.2018.01.003_bib0430","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1200\/JCO.2012.46.0816","article-title":"Prospective study of tailoring whole-body dual-modality (18F)-fluorodeoxyglucose positron emission tomography\/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging","volume":"31","author":"Tang","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2018.01.003_bib0435","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/hed.20974","article-title":"Comparison of 4 modalities for distant metastasis staging in endemic nasopharyngeal carcinoma","volume":"31","author":"Chua","year":"2009","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2018.01.003_bib0440","doi-asserted-by":"crossref","first-page":"e8084","DOI":"10.1097\/MD.0000000000008084","article-title":"Prognostic value of maximum standard uptake value, metabolic tumor volume, and total lesion glycolysis of positron emission tomography\/computed tomography in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis","volume":"96","author":"Li","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.canrad.2018.01.003_bib0445","doi-asserted-by":"crossref","first-page":"13612","DOI":"10.18632\/oncotarget.7253","article-title":"Establishment of an integrated model incorporating standardised uptake value and N-classification for predicting metastasis in nasopharyngeal carcinoma","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canrad.2018.01.003_bib0450","doi-asserted-by":"crossref","first-page":"24","DOI":"10.21037\/cco.2016.03.16","article-title":"Clinical significance of hypoxia in nasopharyngeal carcinoma with a focus on existing and novel hypoxia molecular imaging","volume":"5","author":"Yip","year":"2016","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.canrad.2018.01.003_bib0455","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2967\/jnumed.113.126615","article-title":"A comparison of the imaging characteristics and microregional distribution of 4 hypoxia PET tracers","volume":"55","author":"Carlin","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.canrad.2018.01.003_bib0460","doi-asserted-by":"crossref","first-page":"430","DOI":"10.21037\/qims.2016.06.11","article-title":"Functional magnetic resonance imaging techniques and their development for radiation therapy planning and monitoring in the head and neck cancers","volume":"6","author":"Yuan","year":"2016","journal-title":"Quant Imaging Med Surg"},{"key":"10.1016\/j.canrad.2018.01.003_bib0465","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40644-016-0080-6","article-title":"Functional MRI for the prediction of treatment response in head and neck squamous cell carcinoma: potential and limitations","volume":"16","author":"King","year":"2016","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.canrad.2018.01.003_bib0470","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1158\/1078-0432.CCR-08-1287","article-title":"Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck","volume":"15","author":"Kim","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.canrad.2018.01.003_bib0475","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.ijrobp.2011.03.006","article-title":"Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases","volume":"82","author":"Shukla-Dave","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2018.01.003_bib0480","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3174\/ajnr.A4296","article-title":"Feasibility analysis of the parametric response map as an early predictor of treatment efficacy in head and neck cancer","volume":"36","author":"Baer","year":"2015","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.canrad.2018.01.003_bib0485","doi-asserted-by":"crossref","first-page":"e23421","DOI":"10.7554\/eLife.23421","article-title":"Defining the biological basis of radiomic phenotypes in lung cancer","volume":"6","author":"Grossmann","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.canrad.2018.01.003_bib0490","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3174\/ajnr.A4285","article-title":"Using texture analysis to determine Human papillomavirus status of oropharyngeal squamous cell carcinomas on CT","volume":"36","author":"Buch","year":"2015","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.canrad.2018.01.003_bib0495","doi-asserted-by":"crossref","first-page":"S467","DOI":"10.1016\/j.ijrobp.2013.06.1236","article-title":"FDG-pet image-derived features can determine hpv status in head-and-neck cancer","volume":"87","author":"Vallieres","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2018.01.003_bib0500","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1158\/1078-0432.CCR-16-2910","article-title":"Radiomics features of multiparametric MRI as novel prognostic factors in advanced nasopharyngeal carcinoma","volume":"23","author":"Zhang","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.canrad.2018.01.003_bib0505","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/nbm.2962","article-title":"Texture-based and diffusion-weighted discrimination of parotid gland lesions on MR images at 3.0 Tesla","volume":"26","author":"Fruehwald-Pallamar","year":"2013","journal-title":"NMR Biomed"},{"key":"10.1016\/j.canrad.2018.01.003_bib0510","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.radonc.2011.07.025","article-title":"(18F) -FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer","volume":"101","author":"Delouya","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2018.01.003_bib0515","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ijrobp.2008.04.059","article-title":"Combined (18F)-FDG-PET\/CT imaging in radiotherapy target delineation for head-and-neck cancer","volume":"73","author":"Guido","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2018.01.003_bib0520","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1148\/radiol.2331030660","article-title":"Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen","volume":"233","author":"Daisne","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.canrad.2018.01.003_bib0525","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s00259-006-0363-4","article-title":"A gradient-based method for segmenting FDG-PET images: methodology and validation","volume":"34","author":"Geets","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.canrad.2018.01.003_bib0530","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2967\/jnumed.110.075689","article-title":"Molecular imaging in radiotherapy planning for head and neck tumors","volume":"52","author":"Gr\u00e9goire","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.canrad.2018.01.003_bib0535","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/1748-717X-8-262","article-title":"Dose escalation to high-risk sub-volumes based on non-invasive imaging of hypoxia and glycolytic activity in canine solid tumors: a feasibility study","volume":"8","author":"Clausen","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2018.01.003_bib0540","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.radonc.2014.02.005","article-title":"Effect of (18F) -FMISO stratified dose-escalation on local control in FaDu hSCC in nude mice","volume":"111","author":"Schutze","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2018.01.003_bib0545","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/hed.10037","article-title":"FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma","volume":"24","author":"Brun","year":"2002","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2018.01.003_bib0550","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00259-011-1759-3","article-title":"Early FDG PET at 10 or 20Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer","volume":"38","author":"Hentschel","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.canrad.2018.01.003_bib0555","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.radonc.2012.03.001","article-title":"Can \u201cearly\u201d and \u201clate\u201d (18F)-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy?","volume":"103","author":"Castaldi","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2018.01.003_bib0560","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3174\/ajnr.A3706","article-title":"Fractional change in apparent diffusion coefficient as an imaging biomarker for predicting treatment response in head and neck cancer treated with chemoradiotherapy","volume":"35","author":"Matoba","year":"2014","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.canrad.2018.01.003_bib0565","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.ijrobp.2014.08.350","article-title":"Automated segmentation of the parotid gland based on atlas registration and machine learning: a longitudinal MRI study in head-and-neck radiation therapy","volume":"90","author":"Yang","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2018.01.003_bib0570","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1158\/0008-5472.CAN-14-3477","article-title":"Noninvasive imaging of tumor PD-L1 expression using radiolabeled anti-PD-L1 antibodies","volume":"75","author":"Heskamp","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.canrad.2018.01.003_bib0575","doi-asserted-by":"crossref","first-page":"538","DOI":"10.2967\/jnumed.116.177659","article-title":"Practical immuno-PET radiotracer design considerations for Human immune checkpoint imaging","volume":"58","author":"Mayer","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.canrad.2018.01.003_bib0580","doi-asserted-by":"crossref","first-page":"529","DOI":"10.21037\/atm.2016.12.57","article-title":"Going into BATTLE: umbrella and basket clinical trials to accelerate the study of biomarker-based therapies","volume":"4","author":"Rashdan","year":"2016","journal-title":"Ann Transl Med"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321818300507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321818300507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:28:27Z","timestamp":1761136107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321818300507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S1278321818300507"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2018.01.003","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adaptive radiotherapy for head and neck cancers: Fact or fallacy to improve therapeutic ratio?","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2018.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}